Target intelligence / Profile preview

Escherichia coli O25B O-antigen epitope (O25B O-antigen)

Target
O25B O-antigen
Molecular classification
Bacterial surface antigen, Lipopolysaccharide component, Carbohydrate epitope
01

Overview

The Escherichia coli O25B O-antigen epitope is a specific carbohydrate structure found within the lipopolysaccharide (LPS) layer of certain extraintestinal pathogenic E. coli (ExPEC) strains, most notably the multi-drug resistant ST131 clone. This O-antigen serves as a critical virulence factor by protecting the bacterium from host complement-mediated killing and facilitating colonization of host tissues. Due to its high prevalence in antibiotic-resistant infections, particularly urinary tract infections and neonatal sepsis, it has become a primary target for novel therapeutic interventions. Current drug development efforts focus on using this epitope as a vaccine candidate or as a target for monoclonal antibodies to provide passive immunity. By targeting the O25B epitope, these therapies aim to enhance opsonophagocytosis and neutralize the pathogen's ability to cause systemic infection.

Other names
Escherichia coli O25B O-antigenE. coli O25B O-antigenO25B antigenO25B lipopolysaccharide epitope
02

Biological functions

Bacterial cell wall structural componentImmune evasionPathogenesisSerum resistanceHost colonization
03

Disease associations

InfectionUrinary tract infectionBacteremiaNeonatal sepsisMeningitis
04

Safety considerations

Potential for serotype replacementImmunogenicity variabilityCross-reactivity with commensal flora
05

Interacting drugs

Exopec (JNJ-64400141)

2 more in the full profile.

06

Biomarkers

O25B-specific antibody titersPresence of E. coli ST131 cloneO25B-positive bacteremia

Beyond the preview

Go deeper on Escherichia coli O25B O-antigen epitope (O25B O-antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli O25B O-antigen epitope (O25B O-antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call